
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
[ Wed, May 25th 2022 ]: WOPRAI
Leland Gershell Initiated (TRVI) at Buy and Held Target at $10 on, May 25th, 2022


🞛 This publication is a summary or evaluation of another publication
Leland Gershell of Oppenheimer, Initiated "Trevi Therapeutics, Inc." (TRVI) at Buy and Held Target at $10 on, May 25th, 2022.
Leland has made no other calls on TRVI in the last 4 months.
There is 1 other peer that has a rating on TRVI. Out of the 1 peers that are also analyzing TRVI, 0 agree with Leland's Rating of Hold.
This is the rating of the analyst that currently disagrees with Leland
- Nathan Weinstein of "Aegis Capital" Initiated at Strong Buy and Held Target at $10 on, Tuesday, March 29th, 2022